264 related articles for article (PubMed ID: 20860816)
1. Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer.
Waalkes S; Atschekzei F; Kramer MW; Hennenlotter J; Vetter G; Becker JU; Stenzl A; Merseburger AS; Schrader AJ; Kuczyk MA; Serth J
BMC Cancer; 2010 Sep; 10():503. PubMed ID: 20860816
[TBL] [Abstract][Full Text] [Related]
2. Caveolin 1 mRNA is overexpressed in malignant renal tissue and might serve as a novel diagnostic marker for renal cancer.
Waalkes S; Eggers H; Blasig H; Atschekzei F; Kramer MW; Hennenlotter J; Tränkenschuh W; Stenzl A; Serth J; Schrader AJ; Kuczyk MA; Merseburger AS
Biomark Med; 2011 Apr; 5(2):219-25. PubMed ID: 21473727
[TBL] [Abstract][Full Text] [Related]
3. Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas.
Cheung C; Vesey D; Cotterill A; Douglas M; Gobe G; Nicol D; Johnson D
Int J Urol; 2005 Jan; 12(1):17-28. PubMed ID: 15661050
[TBL] [Abstract][Full Text] [Related]
4. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
[TBL] [Abstract][Full Text] [Related]
5. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
[TBL] [Abstract][Full Text] [Related]
6. Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma.
Ha YS; Lee GT; Kim YH; Kwon SY; Choi SH; Kim TH; Kwon TG; Yun SJ; Kim IY; Kim WJ
World J Surg Oncol; 2014 Sep; 12():288. PubMed ID: 25227434
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of kidney cancer: association of hyaluronic acid family with histological subtypes and metastasis.
Chi A; Shirodkar SP; Escudero DO; Ekwenna OO; Yates TJ; Ayyathurai R; Garcia-Roig M; Gahan JC; Manoharan M; Bird VG; Lokeshwar VB
Cancer; 2012 May; 118(9):2394-402. PubMed ID: 21887686
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of clinical significance of stem-cell related factors in renal cell cancer.
Liu Y; Zhang C; Fan J; Xiao L; Yin B; Zhou L; Xia S
World J Surg Oncol; 2011 Oct; 9():121. PubMed ID: 21982273
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.
Sandlund J; Ljungberg B; Wikström P; Grankvist K; Lindh G; Rasmuson T
Acta Oncol; 2009; 48(6):909-14. PubMed ID: 19322701
[TBL] [Abstract][Full Text] [Related]
10. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes.
Rohan S; Tu JJ; Kao J; Mukherjee P; Campagne F; Zhou XK; Hyjek E; Alonso MA; Chen YT
Clin Cancer Res; 2006 Dec; 12(23):6937-45. PubMed ID: 17145811
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of cyclooxygenase-1 correlates with poor prognosis in renal cell carcinoma.
Yu ZH; Zhang Q; Wang YD; Chen J; Jiang ZM; Shi M; Guo X; Qin J; Cui GH; Cai ZM; Gui YT; Lai YQ
Asian Pac J Cancer Prev; 2013; 14(6):3729-34. PubMed ID: 23886173
[TBL] [Abstract][Full Text] [Related]
13. Mechanism and function of decreased FOXO1 in renal cell carcinoma.
Zhou L; Yin B; Liu Y; Hong Y; Zhang C; Fan J
J Surg Oncol; 2012 Jun; 105(8):841-7. PubMed ID: 22213032
[TBL] [Abstract][Full Text] [Related]
14. Tr-KIT/c-KIT ratio in renal cell carcinoma.
Ergün S; Altay DU; Güneş S; Büyükalpelli R; Karahan SC; Tomak L; Abur Ü
Mol Biol Rep; 2019 Oct; 46(5):5287-5294. PubMed ID: 31342295
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.
Chen D; Gassenmaier M; Maruschke M; Riesenberg R; Pohla H; Stief CG; Zimmermann W; Buchner A
J Urol; 2014 Feb; 191(2):479-86. PubMed ID: 24012533
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the expression of CARMA3 as a prognostic tumor marker in renal cell carcinoma.
Wu GL; Yuan JL; Huang XD; Rong JF; Zhang LX; Liu YP; Wang FL
Tumour Biol; 2013 Dec; 34(6):3431-5. PubMed ID: 23771851
[TBL] [Abstract][Full Text] [Related]
17. Quantification of G250 mRNA expression in renal epithelial neoplasms by real-time reverse transcription-PCR of dissected tissue from paraffin sections.
Bismar TA; Bianco FJ; Zhang H; Li X; Sarkar FH; Sakr WA; Grignon DJ; Che M
Pathology; 2003 Dec; 35(6):513-7. PubMed ID: 14660102
[TBL] [Abstract][Full Text] [Related]
18. Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma.
Dong Y; Ma WM; Yang W; Hao L; Zhang SQ; Fang K; Hu CH; Zhang QJ; Shi ZD; Zhang WD; Fan T; Xia T; Han CH
BMC Cancer; 2021 Oct; 21(1):1135. PubMed ID: 34688260
[TBL] [Abstract][Full Text] [Related]
19. Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.
Shioi K; Komiya A; Hattori K; Huang Y; Sano F; Murakami T; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
Clin Cancer Res; 2006 Dec; 12(24):7339-46. PubMed ID: 17189405
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a multicolour fluorescence in situ hybridisation-based assay for subtyping of renal cell tumours.
Sanjmyatav J; Hauke S; Gajda M; Hartmann A; Moch H; Meyer B; Pryalukhin A; Grimm MO; Junker K
Eur Urol; 2013 Oct; 64(4):689-91. PubMed ID: 23790440
[No Abstract] [Full Text] [Related]
[Next] [New Search]
